SCHEMBL18459272

SCHEMBL18459272

C[C@H](N)c1ccc(CN2CC3(C2)CN(C(=O)OC(C)(C)C)C3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.38
▸ HTT P42858 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PARP1 P09874 1/20 0.37
▸ VEGFA P15692 1/20 0.37
▸ EGLN1 Q9GZT9 1/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ GPR119 Q8TDV5 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21541346 1.00 RORC (0.50) RORCALDH1A1HTTNPC1MAPT
SCHEMBL18459273 0.84 HTT (0.51) ALDH1A1HTTNPC1MAPTMAPK1
SCHEMBL18459829 0.84 HTT (0.51) ALDH1A1HTTNPC1MAPTMAPK1
SCHEMBL30620505 0.83 RORC (0.53) RORCALDH1A1HTTPARP1VEGFA
SCHEMBL27253377 0.83 RORC (0.56) RORCPARP1MGLLHDAC1
SCHEMBL19173661 0.83 RORC (0.53) RORCALDH1A1MAPK1OPRD1OPRK1
SCHEMBL21518022 0.83 ALDH1A1 (0.42) ALDH1A1HTTSMN1; SMN2CYP2D6HRH3
SCHEMBL21518024 0.83 ALDH1A1 (0.42) ALDH1A1HTTSMN1; SMN2CYP2D6HRH3
SCHEMBL20304882 0.82 RORC (0.52) RORCALDH1A1HTTMAPTL3MBTL1
SCHEMBL23003391 0.81 CYP3A4 (0.52) RORCALDH1A1CYP2D6GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10253041-B2 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant IDH1 inhibitors ELI LILLY AND COMPANY (US) 2019-04-09 — — US disclosed
US-20180118759-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIR USE AS MUTANT IDH1 INHIBITORS ELI LILLY AND COMPANY 2018-05-03 — — US disclosed
WO-2017019429-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIT USE AS MUTANT IDH1 INHIBITORS ELI LILLY AND COMPANY (US) 2017-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253041-B2 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant IDH1 inhibitors IDH1, IDH3A, IDH3B RORC 2977/4885ALDH1A1 17/4885HTT 724/4885
US-20180118759-A1 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AND THEIR USE AS MUTANT IDH1 INHIBITORS IDH1, IDH3A, IDH3B RORC 2977/4885ALDH1A1 17/4885HTT 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback